Immune Effects of Acute and Regular Exercise
Biphasic lymphocyte response, mechanisms, and anticancer implications
Fiuza-Luces C et al. (2023). The effect of physical exercise on anticancer immunity. Nature Reviews Immunology. doi:10.1038/s41577-023-00943-0 | Puta C et al. (2025). Kompendium der Sportmedizin. doi:10.1007/978-3-662-68883-0 (Abb. 22.4). Created with BioRender.
| Parameter | Acute Exercise (single bout) | Regular Exercise (training) |
|---|---|---|
| NK cell count (blood) | ↑ 8–10× during exercise | Normalised between sessions |
| NK cell cytotoxicity | ↑ ~60% at 1 h post-exercise | ↑ sustained (training effect) |
| CD8⁺ T cells | ↑ 2–3× during exercise | ↑ naive subsets; ↓ senescent |
| γδ T cells | ↑ 2–3× during exercise | ↑ with high aerobic fitness |
| Lymphocytes (24 h) | ↓ 30–50% (lymphopenia) | Baseline maintained |
| Systemic inflammation | Transient ↑ (IL-6) then anti-inflam. | ↓ chronic inflammation |
| Tumour infiltration | Immediate redistribution | ↑ immune infiltrates over weeks |
| T cell repertoire | Preferential mobilisation of EM/EMRA | ↑ naive; ↓ senescent/exhausted |
| Gut microbiome | Minimal acute change | ↑ alpha diversity; ↓ tumour-promoting bacteria |
| Adoptive therapy potential | ↑ cytotoxic cells in blood (window) | Sustained pool of fit immune cells |
In humans, acute dynamic exercise bouts lasting ≥20–60 min induce a biphasic response in lymphocytes. The initial response is characterised by dramatic lymphocytosis that affects mainly NK cells, which increase several-fold above baseline levels in the blood. The most responsive NK cells are the mature KIR⁺ or NKG2A⁻ NK cells, CD8⁺ T cells and γδ T cells (which increase by approximately twofold and threefold, respectively) are also mobilised in response to acute exercise.
Acute exercise preferentially mobilises subsets of CD8⁺ T cells and CD3⁺CD56⁺ NK T-like cells that exhibit surface phenotypes associated with increased differentiation (for example, KLRG1⁺, CD57⁺ and CD28⁻) and gene expression programmes associated with antitumour activity, and also mobilises CD14⁺CD16⁺ monocytes over classical CD14⁺CD16⁻ monocytes. Lymphocyte subtypes that are not typically involved in cytotoxicity (such as CD4⁺ T cells and B cells) are recruited into the blood to a significantly lesser extent.
Lymphocyte mobilisation during exertion is proportional to effort intensity and is driven by increased blood pressure and shear forces that cause demargination from the vascular and tissue reservoirs (the lung, liver and spleen), which boosts the number of leucocytes travelling in the main axial blood flow of the peripheral circulation. Mobilisation is also principally promoted by adrenaline stimulation of β₂-adrenergic receptors on the surface of lymphocytes, leading to endothelial detachment and recirculation of lymphocytes into the bloodstream.
Blood lymphocyte counts start to decrease during recovery after exercise, with a nadir at approximately 1–2 hours after exertion. Transient lymphopenia below pre-exercise levels is frequent, affecting mostly NK and CD8⁺ T cells and gradually returning to baseline levels, usually within 24 hours. This acute, transient lymphopenia does not reflect immunosuppression and might occur in the context of an improved immunosurveillance. Indeed, in healthy individuals, NK cell cytotoxic capacity against lymphoma and multiple myeloma cell lines increases by 60% at 1 hour after exertion, which is accompanied by a decrease in the proportion of NK cells that express the inhibitory receptor CD158b and an increase in NK cells that express the activating receptor NKG2C.
Fluorescent cell tracking studies in rodents revealed that T cells are largely redeployed from the spleen to target organs such as the lung, bone marrow and gut. Additionally, acute physical exercise preferentially mobilises highly differentiated T cells into the circulation, many of which display phenotypes associated with exhaustion and terminal differentiation. Some of these mobilised cells appear to be more susceptible to exercise-induced apoptosis, which may create 'vacant space' (especially if acute exertion bouts are repeated frequently) for new naive T cells to take occupancy.
The long-term beneficial effects of daily regular exercise might be due to the cumulative impact of 'repeated acute exercise bouts' and the subsequent salutary effects during a few hours per day. Since each bout of exercise induces myokine or exerkine secretion and induces the redeployment of massive numbers of lymphocytes, the effects of regular exercise on immune function in general and on antitumour immune function in particular might be linked, at least partly, to the progressive accumulation of frequent acute episodes of mobilisation or redistribution of effector lymphocytes.
Regular exercise can increase natural killer (NK) cell cytotoxic activity against tumour cells, which can be accompanied by changes at the NK cell proteome level. Regular exercise might reshape the T cell repertoire by potentially increasing the proportion of naive CD8⁺ T cells while also increasing immune cell infiltrates in tumours. In addition, regular exercise attenuates chronic systemic inflammation — a condition associated with higher cancer risk — and increases gut microbiota diversity, while also potentially reducing the levels of tumour-promoting bacteria.
Although a single exercise session mobilises NK cells into the bloodstream, this does not suffice to increase prostate NK cell infiltrates. Yet, a higher number of training sessions over an 8-week period correlated with greater prostate NK cell infiltrates in patients with this malignancy, and good adherence to the programme (up to 4 days a week) led to higher increases in tumour infiltrates at end intervention (mean change of +1.60 cells mm⁻²) compared with non-exercising controls (+0.44 cells mm⁻²).
Through its ability to rapidly mobilise and increase circulating T cells, acute exercise has been postulated as a method to enrich T cells in the blood before leukapheresis, which will then be used for adoptive transfer immunotherapies that require ex vivo expansion (such as CAR T cells).